Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2332255B is a highly potent and selective TRPC3 and TRPC6 antagonist, exhibiting IC50 values of 5 nM and 4 nM for rat TRPC3 and rat TRPC6, respectively. Furthermore, GSK2332255B demonstrates exceptional selectivity, surpassing a ≥100-fold difference when compared to other calcium-permeable channels.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | GSK2332255B is a highly potent and selective TRPC3 and TRPC6 antagonist, exhibiting IC50 values of 5 nM and 4 nM for rat TRPC3 and rat TRPC6, respectively. Furthermore, GSK2332255B demonstrates exceptional selectivity, surpassing a ≥100-fold difference when compared to other calcium-permeable channels. |
Targets&IC50 | TRPC6 (rat):4 nM (IC50), TRPC3 (rat):5 nM (IC50) |
In vitro | GSK255B effectively inhibits the activation of Nuclear Factor of Activated T-cells (NFAT) by Angiotensin II (Ang II) in a dose-dependent manner in HEK293T cells overexpressing TRPC3, with concentrations of 0.01, 0.1, and 1 μM being tested. This inhibitory effect extends to HEK293T cells expressing a mutant TRPC6 channel, where the amino acids T70 and S322 are mutated to glutamic acid (SETE)[1]. Additionally, at a concentration of 10 μM, GSK255B prevents calcium influx induced by 20 μM Phenylephrine in rat neonatal cardiac myocytes. The compound also blocks the signaling pathways leading to cell hypertrophy triggered by either angiotensin II or endothelin-1 in both HEK293T cells and cardiac myocytes from neonatal and adult rats[1]. |
Molecular Weight | 411.88 |
Formula | C18H19ClFN3O3S |
CAS No. | 1366233-41-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2332255B 1366233-41-1 GSK-2332255B inhibitor inhibit